Allarity (ALLR) news

Recent news

Allarity Therapeutics - has patent protection for Stenoparib DRP in Europe and Australia into 2039

AInvest Wire · Jun 30, 2026

Allarity Therapeutics - granted patent term extends into April 2042

Allarity Therapeutics, Inc. (NASDAQ: ALLR) has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its stenoparib DRP® companion diagnostic, a development that could extend the patent term for the drug and diagnostic combination into April 2042. The patent is…

AInvest Wire · Jun 30, 2026

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by